Navigation Links
Serigne Gueye Ndiaye Comments on New Sunscreen Labeling
Date:6/18/2013

San Francisco, California (PRWEB) June 18, 2013

Serigne Gueye Ndiaye, who practices dermatology in San Francisco, California, is issuing comment on a new article that explains the changing rules regarding sunscreen. Starting this summer, sunscreen brands found on store shelves will need to meet new labeling requirements from the Food and Drug Administration. These new rules were created to help clear up consumer misconceptions regarding proper usage and effectiveness of sunscreen.

With the new labeling laws, sunscreen that has an SPF of 15 or lower must come with a warning label that states it will not protect against skin cancer. Products can no longer claim that they are waterproof, only water-resistant. There is also some debate about whether sunscreens with SPF’s that are higher than 50 should even remain on the market, since it is not completely clear whether these products are actually more effective. There is also concern that consumers may be lulled into a false sense of security by the high SPF on the bottle, thus avoiding reapplying the product regularly.

The changes come partially as a response to ever increasing skin cancer rates, even as sunscreen sales bring in $1B each year. Melanoma diagnoses have steadily climbed nearly two percent since 2000, and are becoming frighteningly common among young, white women.

Some experts attribute this to improper use of sunscreen, where people either apply too little or fail to reapply the substance every two hours as advised. There is also concern that many sunscreens protect users from ultraviolet B rays, but do not necessarily also offer protection from ultraviolet A rays. These are the rays that are known to cause skin
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on NBC Report Detailing Robotic Surgery Complications
2. Merrill DataSite Releases New Comments: Cash Reserves and M&A Options
3. Rottenstein Law Group LLP Comments on Drugmakers’ Cooperation With Safety Review of Byetta, Januvia, Victoza
4. Wright Hip Lawsuit News: Bernstein Liebhard LLP Notes Comments on Report Detailing Wright Hip Replacement Lawsuits, Other Metal-on-Metal Hip Claims
5. Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on Intuitive Surgical’s Decision to Replace Defective da Vinci Surgical Instrument
6. DePuy ASR Hip Recall: Bernstein Liebhard LLP Comments on DePuy’s Motion to Strike Costs in Wake of $8.25 Million DePuy ASR Lawsuit Judgment
7. Dr. Anthony Schepsis Comments on New ACL Repair Strategy
8. Voices Against Brain Cancer Comments on New Discovery Made by Researchers in Regards to the Tie between Brain Cancer and Genetics
9. Mesh Lawsuit News: Bernstein Liebhard LLP Comments on Study to Investigate Safety, Benefits of Boston Scientific Mesh
10. Attorney Article Comments on 401(k) Fees Documentary, "The Retirement Gamble"
11. Biomet Hip Replacement Lawsuits: Bernstein Liebhard LLP Comments on Ongoing Biomet M2a Magnum Hip Replacement Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... HealthDay Reporter TUESDAY, July 29, ... are vital to good health and a long life, but ... of fruits and vegetables each day, additional daily servings don,t ... The human body may only be able to effectively process ... its ability to absorb important nutrients from extra helpings, said ...
(Date:7/30/2014)... July 30, 2014 Florida A&M ... Renee Gordon and biochemistry professor Ngozi Ugochukwu, Ph.D., ... research as Fulbright Scholars. The prestigious Fulbright Scholars ... program that awards grants to students, faculty or ... research abroad. Both Gordon and Ugochukwu will conduct ...
(Date:7/30/2014)... July 30, 2014 BuyCBDOnline.co , ... products, is pleased to announce that it is has ... of top quality products available for immediate shipping. , ... in it's infancy stages," site founder Jason Liss says. ... a wide variety of unique products that are available ...
(Date:7/30/2014)... 30, 2014 The Independent Woman ... be holding 5 free financial workshops in the San ... The goal of these workshops is our collective success, ... of financial empowerment. , These workshops were designed by ... a successful investor, entrepreneur, and bestselling author (Rich Woman ...
(Date:7/30/2014)... TX (PRWEB) July 30, 2014 ... the increase of personal health expenditure as well ... health care system, China diagnostic reagent industry has ... occupy over 90%. In 2013, Chinese in vitro ... RMB16.61 billion came from in vitro diagnostic reagents. ...
Breaking Medicine News(10 mins):Health News:Fruits, Veggies May Have Their Limits in Boosting Lifespan 2Health News:Fruits, Veggies May Have Their Limits in Boosting Lifespan 3Health News:FAMU Professor and Engineering Student Named Fulbright Scholars 2Health News:FAMU Professor and Engineering Student Named Fulbright Scholars 3Health News:Delicious, Unique CBD-Rich Hemp Oil Product Debuts from BuyCBDOnline.co 2Health News:Delicious, Unique CBD-Rich Hemp Oil Product Debuts from BuyCBDOnline.co 3Health News:The Independent Woman is Coming to the San Francisco Area in August - Women Helping Women Reach Their Financial Goals 2Health News:The Independent Woman is Coming to the San Francisco Area in August - Women Helping Women Reach Their Financial Goals 3Health News:China Diagnostic Reagent Industry (biochemical, molecular & immunodiagnostic) 2016 Forecasts in New Research Report at ChinaMarketResearchReports.com 2Health News:China Diagnostic Reagent Industry (biochemical, molecular & immunodiagnostic) 2016 Forecasts in New Research Report at ChinaMarketResearchReports.com 3Health News:China Diagnostic Reagent Industry (biochemical, molecular & immunodiagnostic) 2016 Forecasts in New Research Report at ChinaMarketResearchReports.com 4
... of helping military and,vets since 1916, NEW HAVEN, Conn., ... worth of wheelchairs to veterans in,need at four VA Hospital ... long history of K of C service to the men ... has purchased 2000 wheelchairs and partnered,with the Wheelchair Foundation to ...
... orthopaedic surgery feel less pain and leave the ... pouch that delivers local anesthetic agents and,blocks pain ... at The Children,s Hospital of Philadelphia adapted the ... the November 2007 issue of the journal,Anesthesia & ...
... Findings in animal tests may lead to new therapies ... (HealthDay News) -- Blocking a substance called peroxynitrite, a ... prevent the development of tolerance to the pain-relieving effects ... Saint Louis University of Medicine researchers. , They said ...
... Goal to provide access to full healthcare benefits for ... teacher training, student,programs; farmers to compete in the global ... and education programs will be major issues on the ... in Cairo. The,NDP is looking at ways to accelerate ...
... Million Awarded for Medical and Dental Clinic Services, ... Dr. Calvin B. Johnson today announced the award ... Challenge Grants to expand access to,primary medical and ... grants are awarded to nonprofit organizations, local governments,and ...
... HAVEN, Conn., Nov. 2 RHEI Pharmaceuticals, Inc., ... medicines to the China market, will be presenting, ... Healthcare Conference on Monday,November 5, 2007 at 2:20 ... turnkey solution for any,company wishing to gain access ...
Cached Medicine News:Health News:Knights of Columbus to Distribute Wheelchairs to Veterans in Need 2Health News:Anesthesia Pouch Allows Children to Go Home Sooner After Surgery 2Health News:Anesthesia Pouch Allows Children to Go Home Sooner After Surgery 3Health News:Blocking Potent Oxidant Could Prevent Morphine Tolerance 2Health News:Social Justice Issues Take Main Stage at Egypt's National Democratic Party Convention 2Health News:PA Health Department Awards Community Primary Care Challenge Grants 2
(Date:7/29/2014)... -- Sequenom, Inc. (NASDAQ: SQNM ), a life ... total revenues of $39.8 million for the second quarter ... of $24.5 million for the second quarter of 2013. ... sold on May 30, 2014, has been accounted for ... been excluded from continuing operations for all periods. ...
(Date:7/29/2014)...  EnteroMedics Inc. (NASDAQ: ETRM ), the ... obesity, metabolic diseases and other gastrointestinal disorders, today announced ... August 7, 2014 at 11:00 AM Eastern Time to ... 30, 2014 and to provide a business update. ... conference call may be accessed by dialing (877) 280-7473 ...
(Date:7/29/2014)... 2014  Synthetic Biologics, Inc. (NYSE MKT: SYN), a ... specific pathogens that cause serious infections and diseases, announced ... in the Company,s stock, the NYSE MKT (the "Exchange") ... practice. The Company stated that its policy is not ... Synthetic Biologics, Inc. Synthetic Biologics, Inc. (NYSE ...
Breaking Medicine Technology:Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 2Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 3Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 4Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 5Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 6Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 7Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 8Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 9Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 10Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 11Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 12Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 13Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 14Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 15Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 16EnteroMedics to Host Second Quarter 2014 Financial Results and Business Update Conference Call 2EnteroMedics to Host Second Quarter 2014 Financial Results and Business Update Conference Call 3Synthetic Biologics, Inc. States that Its Policy is Not to Comment on Unusual Market Activity 2
... diagnosisTAMPA, Fla., May 14 Moffitt Cancer ... have signed a license agreement on phospholipid ... been granted exclusive worldwide rights to Moffitt,s interests in ... maintenance fees, and royalties on sales. Moffitt and Frantz ...
... indicate statistically significant improvement in ACR20 responses over ... MEDX ) today announced that the ... active rheumatoid arthritis (RA) receiving methotrexate successfully met ... recently completed 70-patient multi-center, randomized, double-blind, placebo-controlled Phase ...
Cached Medicine Technology:Moffitt Cancer Center Signs Licensing Agreement with Frantz BioMarkers, LLC 2Medarex Announces Primary Endpoint Achieved in MDX-1100 Anti-IP-10 Antibody Phase 2 Trial for Rheumatoid Arthritis 2Medarex Announces Primary Endpoint Achieved in MDX-1100 Anti-IP-10 Antibody Phase 2 Trial for Rheumatoid Arthritis 3Medarex Announces Primary Endpoint Achieved in MDX-1100 Anti-IP-10 Antibody Phase 2 Trial for Rheumatoid Arthritis 4
... benefits of fibre bronchoscopy: The HF-compatible V ... all other fibre bronchoscopes are measured., ... PENTAX, including the FB-19TV, FB-18V and FB-15V ... and the pediatric FB-8V, offer much better ...
... therapeutic fiberoptic bronchoscopes offers ... channel with a slim ... channel allows for improved ... of cytology brushes. The ...
... from the latest 60 series bronchoscopes., ... range, focussing on providing clinicians with ... Olympus has a impressive range of ... in the respiratory tract to meet ...
... High performance fiberoptic imaging from ... ,Olympus has improved its fiberscope range, ... specifications and enhanced image performance. Olympus ... instruments for diagnosis and therapy in ...
Medicine Products: